FDA Signs Off on First Medical Device for Treating ADHD in Children

4
438

From USA TODAY: “Called the Monarch external Trigeminal Nerve Stimulation (eTNS) System, the prescription-only device is for children ages 7 to 12 who are not taking ADHD prescription medication.

The Monarch eTNS – an instrument the size of a cellphone – is designed for use at home with adult supervision. It connects via wire to a small patch placed on the forehead of the patient, generating a low-level electrical pulse to the brain. […]

A trial of 62 children with moderate to severe ADHD showed subjects using the eTNS had ‘statistically significant improvement’ compared with ADHD children who were given a placebo device.

After four weeks into the study, the average ADHD-RS score – used to measure ADHD – had decreased from 34.1 points to 23.4 points. That’s compared with a decrease of 33.7 to 27.5 points among the placebo group.”

Article →

 

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time

4 COMMENTS

  1. “The FDA said the Monarch eTNS has several side effects – drowsiness, an increase in appetite, trouble sleeping, teeth clenching, headache and fatigue – but no serious adverse events associated with its use.” To me, a child that suffers from these symptoms has serious adverse events.